대한부인종양학회

최신 논문

총 게시글 : 196

Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial 2026-03-17 VIEW : 3
Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO- E/GOG-3041/ENGOT-EN10 trial. 2026-03-17 VIEW : 5
Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial 2026-03-17 VIEW : 9
Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775. 2026-03-17 VIEW : 7
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial 2026-03-17 VIEW : 1
Risk stratification of groin node metastases in vulvar cancer biopsies based on histology and immunohistochemical staining 2026-03-17 VIEW : 1
Checkpoint Inhibition in Gestational Trophoblastic Neoplasia: A Narrative Review on the Reawakening of Antitumor Immunity 2026-03-17 VIEW : 1
Fertility-sparing vs hysterectomy for uterine STUMP: A pragmatic clinical study 2026-03-17 VIEW : 3
Multi-ancestry genome-wide association analyses of polycystic ovary syndrome 2026-03-17 VIEW : 1
Incidence of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Cancer or Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-analysis 2026-03-17 VIEW : 7
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial 2025-12-19 VIEW : 1
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial 2025-12-19 VIEW : 1
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation 2025-12-19 VIEW : 1
Dostarlimab and niraparib in primary advanced ovarian cancer 2025-12-19 VIEW : 3
Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201 2025-12-19 VIEW : 1

1
2
3
4
5
6
7
8
9
10
...
13
14